デジタル診断市場：タイプ別、産業用途別、エンドユーザー別-2025-2030年の世界予測

デジタル診断市場は、2024年には15億4,000万米ドルとなり、2025年には16億3,000万米ドル、CAGR6.17%で成長し、2030年には22億1,000万米ドルに達すると予測されています。

急速に進化するヘルスケア領域では、デジタル診断が病気の発見と管理方法を再定義しつつあります。人工知能、画像技術、分子遺伝学における最近の進歩は、診断手法がますます効果的かつ精密になる変革の時代を示しています。この進化に拍車をかけているのは、従来の診断手順にデジタル機能を統合する、分野横断的研究と技術的ブレークスルーの融合です。技術開発者と臨床医との間の戦略的相互作用は、診断精度を最適化するだけでなく、複数の臨床症状にわたって患者の転帰を向上させるイノベーションを触媒しています。

このような背景から、業界の専門家からヘルスケアの意思決定者までの利害関係者は、患者のケア経路を再構築する上でデジタル診断が果たす重要な役割に注目しています。入念にオーケストレーションされた交響曲のように、新たなデジタルツールと従来の調査手法の統合は、早期発見、個別化治療、疾病管理の改善が達成可能な目標となる未来を作りつつあります。これらの変化は、迅速な診断が最重要視される環境において特に重要であり、データ主導の医療意思決定への世界のシフトの基礎を築くものです。

この包括的な概要では、デジタル診断市場の多面的な側面を捉え、市場動向、変革的シフト、セグメンテーション分析、地域差などに関する適切な洞察を提供します。以下の章では、市場の進化を促進するマーケットカタリストを掘り下げ、この重要な分野を定義する機会と課題の両方について詳細な解説を行う。

デジタル診断の展望を再定義する変革的シフト

デジタル診断の状況は、ここ数年でかつてない変化を遂げています。新たなテクノロジーは、画像診断、リアルタイムでの患者モニタリング、精密な分子解析のギャップを埋めつつあります。最も注目すべき変化の一つは、診断業務への高度な分析の統合が進んでいることです。強化された画像技術と機械学習アルゴリズムが今や重要な推進力となっており、より正確で迅速な疾患の特定を可能にしています。また、データ処理とクラウド接続における革新は、異なる地域や研究機関を超えた協力関係の強化にも道を開いています。

さらに、モバイルヘルスアプリケーションと高度な診断機器の融合により、遠隔地や十分なサービスを受けていない地域へのヘルスケアサービスの提供が容易になりつつあります。この進化は、最先端の診断ツールへのアクセスを民主化するだけでなく、初診から確定診断までの経過時間を短縮します。デジタル病理学、放射線学、ウェアラブル健康モニタリングシステムは現在、従来のケアモデルに革命を起こすことを目的としたエコシステムの中心となっています。研究への継続的な投資と強力な規制の焦点により、市場は疾患の早期発見と個別化治療戦略への着実な移行を目の当たりにしています。

ヘルスケア産業がリアクティブなケアからプロアクティブなケアへと移行する中、こうした動向はデジタルトランスフォーメーションを取り入れることの重要性を強調しています。データサイエンスと従来の診断学の相乗効果により、新たな健康上の脅威や患者のニーズの変化に適応できる弾力的なフレームワークが構築されつつあり、ヘルスケア提供の堅牢で拡張可能な未来が保証されつつあります。

市場のニュアンスを明らかにする主要セグメンテーションインサイト

詳細なセグメンテーション分析により、デジタル診断市場の基本的なダイナミクスにニュアンスのある視点を提供します。市場をタイプ別に評価すると、広範な調査により、デジタル皮膚科学、デジタル病理学、デジタル放射線学、モバイル健康診断、分子・遺伝子診断、ウェアラブル・遠隔モニタリングに分けられることが明らかになりました。この分類は、技術的な進歩と、診断プロセスのあらゆる側面へのデジタル手法の統合が進んでいることを浮き彫りにしています。

さらに、業界のアプリケーションを見ると、心臓病学、感染症学、神経学、腫瘍学などの分野で、デジタル診断が治療へのアプローチ方法にますます影響を及ぼしていることがわかる。これらの領域は、医療課題の広範な範囲を示すだけでなく、診断精度の向上と早期介入による成長機会の重要な部分を占めています。これらの洞察を補完するために、エンドユーザーの属性に基づくセグメンテーションでは、診断研究所や画像診断センター、病院や診療所、学術医療センターと並ぶ研究機関が果たす重要な役割を特定しています。これらの各セグメントは、特定の医療要件に対応するために特殊なデジタルツールを活用することで、市場全体に対して独自の貢献をしています。

市場セグメントを綿密に分析することで、進化する需要をより明確に理解することができ、ニーズに合わせた診断に対応するイノベーションが促進されます。したがって、利害関係者は、さまざまなセグメンテーションの視点からの洞察を織り交ぜることによって、製品開拓、市場参入戦術、資源配分の戦略をより的確に立てることができ、その結果、技術的進歩が臨床上の優先事項や患者の治療基準に効果的に合致するようになります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 政府の好ましい政策と規制支援がデジタル診断に大きな推進力を与えている
    • 遠隔医療および遠隔モニタリングソリューションの採用の増加により、デジタル診断の統合が促進される
    • 早期発見と正確な診断ソリューションを必要とする慢性疾患の増加
  • 抑制要因
    • 高度な技術の導入と専門人材のトレーニングに関連する高コスト
  • 機会
    • ウェアラブル技術を融合したデジタル診断による個別化医療の開発
    • 高度なデータ分析によるデジタル診断ワークフローを合理化する戦略的パートナーシップとコラボレーション
  • 課題
    • データプライバシーの懸念とサイバーセキュリティのリスクが消費者の信頼を損なう
• 市場セグメンテーション分析
  • タイプ：スマートフォンの接続性とポータブルデバイスを活用したモバイルヘルス（mヘルス）診断の需要増加
  • エンドユーザー：これらの厳しい要件を満たすインテリジェンス主導の分析のために、診断ラボや画像センターでデジタル診断の適用が増加しています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 デジタル診断市場：タイプ別

• デジタル皮膚科
• デジタル病理学
• デジタル放射線学
• モバイルヘルス（mヘルス）診断
• 分子および遺伝子診断
• ウェアラブルとリモートモニタリング

第7章 デジタル診断市場業界別アプリケーション

• 心臓病学
• 感染症
• 神経学
• 腫瘍学

第8章 デジタル診断市場：エンドユーザー別

• 診断ラボおよび画像診断センター
• 病院・クリニック
• 調査機関および大学医療センター

第9章 南北アメリカのデジタル診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のデジタル診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのデジタル診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies
• Aidoc
• Becton, Dickinson, and Company
• Bio-Rad Laboratories
• Butterfly Network, inc
• CANON MEDICAL SYSTEMS CORPORATION
• Carestream Health, Inc.
• Danaher Corporation
• FUJIFILM Holdings America Corporation
• GE Healthcare Technologies, Inc.
• Google LLC
• Guardant Health, Inc.
• Hologic, Inc.
• International Business Machines Corp.
• Invitae Corporation
• Koninklijke Philips N.V.
• Microsoft Corporation
• NVIDIA Corporation
• PathAI, Inc.
• Qiagen N.V.
• Roche Diagnostics Corporation
• Siemens Healthineers
• Tempus AI, Inc.
• Thermo Fisher Scientific

LIST OF FIGURES

• FIGURE 1. DIGITAL DIAGNOSTICS MARKET MULTI-CURRENCY
• FIGURE 2. DIGITAL DIAGNOSTICS MARKET MULTI-LANGUAGE
• FIGURE 3. DIGITAL DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 4. DIGITAL DIAGNOSTICS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 15. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 17. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. DIGITAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 23. DIGITAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. DIGITAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIGITAL DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY MOBILE HEALTH (MHEALTH) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR & GENETIC DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY WEARABLE & REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 35. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 52. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 55. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 107. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 119. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 122. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. DIGITAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 151. DIGITAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

The Digital Diagnostics Market was valued at USD 1.54 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 6.17%, reaching USD 2.21 billion by 2030.

In the rapidly evolving realm of healthcare, digital diagnostics are redefining the way diseases are detected and managed. Recent advances in artificial intelligence, imaging technology, and molecular genetics underline a transformative era where diagnostic methodologies are becoming increasingly effective and precise. This evolution is spurred by an amalgamation of cross-disciplinary research and technological breakthroughs that integrate digital capabilities into conventional diagnostic procedures. The strategic interplay between technology developers and clinical practitioners is catalyzing innovations that not only optimize diagnostic accuracy but also enhance patient outcomes across multiple clinical conditions.

In this context, stakeholders ranging from industry experts to healthcare decision-makers have turned their attention to the critical role played by digital diagnostics in reshaping patient care pathways. Much like a carefully orchestrated symphony, the integration of emerging digital tools with traditional methodologies is crafting a future where early detection, personalized treatment, and improved disease management stand as achievable goals. These changes are particularly significant in settings where rapid diagnosis is paramount, thereby laying the foundation for a global shift towards data-driven medical decision-making.

This comprehensive overview captures the multifaceted dimensions of the digital diagnostics market, providing pertinent insights into market trends, transformative shifts, segmentation analyses, and regional variations. The following sections delve deeper into the catalysts driving market evolution and present a detailed narrative on both the opportunities and challenges that define this vital sector.

Transformative Shifts Redefining the Digital Diagnostics Landscape

The landscape of digital diagnostics has experienced unprecedented transformation over the past few years. Emerging technologies are bridging the gap between diagnostic imaging, real-time patient monitoring, and precise molecular analysis. One of the most notable shifts is the increasing integration of advanced analytics into diagnostic practices. Enhanced imaging technologies and machine learning algorithms are now key drivers, enabling more accurate and faster disease identification. Innovations in data processing and cloud connectivity have also paved the way for increased collaboration across different geographic regions and research institutions.

Additionally, the convergence of mobile health applications with sophisticated diagnostic equipment is making it easier to deliver healthcare services to remote and underserved areas. This evolution not only democratizes access to state-of-the-art diagnostic tools but also reduces the time elapsed between initial consultation and confirmatory diagnosis. Digital pathology, radiology, and wearable health monitoring systems are now central to an ecosystem designed to revolutionize traditional care models. With ongoing investments in research and a strong regulatory focus, the market is witnessing a steady transition toward early disease detection and personalized treatment strategies.

As the healthcare industry moves from reactive to proactive care, such trends underscore the importance of embracing digital transformation. The synergy between data science and traditional diagnostics is creating a resilient framework that can adapt to emerging health threats and shifting patient needs, ensuring a robust and scalable future for healthcare delivery.

Key Segmentation Insights Revealing Market Nuances

Detailed segmentation analysis offers a nuanced perspective into the underlying dynamics of the digital diagnostics market. When evaluating the market based on type, extensive studies reveal a division into digital dermatology, digital pathology, digital radiology, mobile health diagnostics, molecular and genetic diagnostics, and wearable and remote monitoring. This categorization highlights both the technical advancements and the growing integration of digital methodologies into every facet of diagnostic processes.

Further, a look into industry applications reveals that digital diagnostics are increasingly influencing the way we approach treatment in areas such as cardiology, infectious diseases, neurology, and oncology. These areas represent not only a broad spectrum of medical challenges but also capture the key opportunities for growth through enhanced diagnostic precision and early intervention. Complementing these insights, the segmentation based on end-user demographics pinpoints the critical roles played by diagnostic laboratories and imaging centers, hospitals and clinics, and research institutes alongside academic medical centers. Each of these segments contributes uniquely to the overall market landscape by leveraging specialized digital tools to address specific medical requirements.

The deliberate dissection of market segments facilitates a clearer understanding of the evolving demand, driving innovations that cater to tailored diagnostic needs. Hence, by interweaving insights from various segmentation perspectives, stakeholders can better strategize product development, market entry tactics, and resource allocations, thereby ensuring that technological advancements are effectively aligned with clinical priorities and patient care standards.

Based on Type, market is studied across Digital Dermatology, Digital Pathology, Digital Radiology, Mobile Health (mHealth) Diagnostics, Molecular & Genetic Diagnostics, and Wearable & Remote Monitoring.

Based on Industry Applications, market is studied across Cardiology, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Diagnostic Laboratories & Imaging Centers, Hospitals & Clinics, and Research Institutes & Academic Medical Centers.

Key Regional Insights Shaping Global Market Trends

Regional dynamics play a pivotal role in dictating the pace and direction of the digital diagnostics market. In the Americas, technological advancements and a strong focus on healthcare innovation create a fertile environment for the adoption of digital solutions. This region benefits from extensive research and high capital investments, leading to rapid market penetration and significant improvements in public health outcomes.

Europe, Middle East & Africa exhibit unique patterns driven by diverse regulatory landscapes, varying levels of technological adoption, and distinct demographic challenges. Regulatory frameworks here are increasingly adapting to integrate digital health trends into clinical practice, providing new avenues for market expansion and horizontal growth in services.

Meanwhile, Asia-Pacific stands out as a region with immense growth potential. The confluence of a large population base, increasing healthcare expenditures, and government initiatives targeted at digital transformation accelerates the demand for innovative diagnostics. These regional insights collectively underscore the importance of tailoring digital diagnostic strategies to local market conditions, ensuring that technological leaps in one part of the world can serve as blueprints for innovations elsewhere.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Digital Diagnostics Frontier

Market leadership in digital diagnostics is strongly influenced by several high-impact companies. Giants like Abbott Laboratories and Agilent Technologies are pioneering the integration of robust hardware with sophisticated digital solutions. Companies such as Aidoc and Becton, Dickinson, and Company have demonstrated the power of artificial intelligence to transform diagnostic imaging and workflow efficiencies in clinical settings. Bio-Rad Laboratories, along with Butterfly Network, inc, are advancing how diagnostics are conducted by incorporating genomic insights with digital platforms.

Established names like CANON MEDICAL SYSTEMS CORPORATION and Carestream Health, Inc. continue to contribute significantly by refining imaging technology and diagnostic software. Firms such as Danaher Corporation and FUJIFILM Holdings America Corporation have accelerated the adoption of digital pathology and radiology systems; while GE Healthcare Technologies, Inc. and Google LLC are setting benchmarks for innovative integration of digital ecosystems in healthcare.

Additionally, Guardant Health, Inc., Hologic, Inc., and International Business Machines Corp. are noteworthy for harnessing data analytics to improve diagnostic precision. Invitae Corporation, Koninklijke Philips N.V., and Microsoft Corporation have also been central to pushing the boundaries in areas such as molecular diagnostics and remote health monitoring. In recent years, companies like NVIDIA Corporation, PathAI, Inc., Qiagen N.V., and Roche Diagnostics Corporation have emerged as frontrunners by merging computational advancements with traditional diagnostics. This trend is further bolstered by Siemens Healthineers, Tempus AI, Inc., and Thermo Fisher Scientific, whose commitment to continuous innovation enables the market to progress toward more personalized, accurate, and efficient diagnostic solutions.

The report delves into recent significant developments in the Digital Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Aidoc, Becton, Dickinson, and Company, Bio-Rad Laboratories, Butterfly Network, inc, CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Inc., Danaher Corporation, FUJIFILM Holdings America Corporation, GE Healthcare Technologies, Inc., Google LLC, Guardant Health, Inc., Hologic, Inc., International Business Machines Corp., Invitae Corporation, Koninklijke Philips N.V., Microsoft Corporation, NVIDIA Corporation, PathAI, Inc., Qiagen N.V., Roche Diagnostics Corporation, Siemens Healthineers, Tempus AI, Inc., and Thermo Fisher Scientific. Actionable Recommendations for Industry Leaders Seeking Competitive Advantage

Leaders looking to leverage digital diagnostics should prioritize strategic investments in research and development to harness new technological advances. Emphasizing collaboration between technology innovators and clinical experts ensures that product development is not only forward-thinking but also closely aligned with patient care needs. It is imperative for organizations to cultivate agile frameworks that enable quick adaptation to technological disruptions and regulatory shifts.

Furthermore, enhancing data integration capabilities across various diagnostic touchpoints will streamline operations and improve the accuracy of clinical decisions. Investing in robust cybersecurity measures is another critical area, as trust becomes an increasingly valued asset in the digital diagnostics arena. Such a focus not only protects sensitive patient data but also enhances overall system reliability and stakeholder confidence.

Developing comprehensive training programs for medical personnel on the new digital tools can smooth the transition to technology-based diagnostics and maximize the return on investment. Additionally, continuous evaluation of market trends and patient needs will empower organizations to align their strategies effectively. By adopting a proactive and forward-looking stance, industry leaders can effectively navigate challenges while capitalizing on emerging market opportunities.

Conclusion: Navigating the Future of Digital Diagnostics with Confidence

The digital diagnostics market stands at the intersection of innovation and clinical excellence. As advanced imaging, real-time monitoring, and digital integration continue to reshape healthcare, it becomes essential for both clinicians and technologists to adopt a unified approach to in-depth diagnostics. The blend of technology and medicine is setting a new benchmark in patient care, offering unprecedented opportunities for early detection, personalized treatments, and finally, improved patient outcomes.

A comprehensive assessment of market segments, regional dynamics, and competitive landscapes reveals a resilient market designed for sustainable growth. Stakeholders who proactively adapt to these shifts are well-positioned to lead this technological revolution and drive the future of healthcare forward. The combined efforts and innovative spirit among industry players herald a promising era where digital solutions empower both clinicians and patients alike, thereby forging a path to a smarter, more efficient healthcare system.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Favorable government policies and regulatory support providing significant impetus to digital diagnostics
    • 5.1.1.2. Increased adoption of telemedicine and remote monitoring solutions fostering digital diagnostics integration
    • 5.1.1.3. Growing prevalence of chronic diseases requiring early detection and precise diagnostic solutions
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with advanced technology implementation and expert workforce training
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of personalized medicine through digital diagnostics by integrating wearable technology
    • 5.1.3.2. Strategic partnerships and collaborations streamlining digital diagnostic workflows with advanced data analytics
  • 5.1.4. Challenges
    • 5.1.4.1. Data privacy concerns and cybersecurity risks undermining consumer trust
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing demand for mobile health (mHealth) diagnostics leveraging smartphone connectivity and portable devices
  • 5.2.2. End-User: Rising application of digital diagnostics in diagnostic laboratories & imaging centers for intelligence-driven analytics to meet these stringent requirements
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Digital Diagnostics Market, by Type

• 6.1. Introduction
• 6.2. Digital Dermatology
• 6.3. Digital Pathology
• 6.4. Digital Radiology
• 6.5. Mobile Health (mHealth) Diagnostics
• 6.6. Molecular & Genetic Diagnostics
• 6.7. Wearable & Remote Monitoring

7. Digital Diagnostics Market, by Industry Applications

• 7.1. Introduction
• 7.2. Cardiology
• 7.3. Infectious Diseases
• 7.4. Neurology
• 7.5. Oncology

8. Digital Diagnostics Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories & Imaging Centers
• 8.3. Hospitals & Clinics
• 8.4. Research Institutes & Academic Medical Centers

9. Americas Digital Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Digital Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Digital Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2024
• 12.2. FPNV Positioning Matrix, 2024
• 12.3. Competitive Scenario Analysis
  • 12.3.1. PocDoc secures GBP 5 million in pre-series A funding to expand its app-based digital diagnostics platform
  • 12.3.2. Digital Diagnostics teams with Google Cloud to accelerate diabetic retinopathy testing in Saudi Arabia
  • 12.3.3. Roche expands digital pathology by integrating over 20 AI algorithms from new collaborators to transform cancer diagnostics
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies
• 3. Aidoc
• 4. Becton, Dickinson, and Company
• 5. Bio-Rad Laboratories
• 6. Butterfly Network, inc
• 7. CANON MEDICAL SYSTEMS CORPORATION
• 8. Carestream Health, Inc.
• 9. Danaher Corporation
• 10. FUJIFILM Holdings America Corporation
• 11. GE Healthcare Technologies, Inc.
• 12. Google LLC
• 13. Guardant Health, Inc.
• 14. Hologic, Inc.
• 15. International Business Machines Corp.
• 16. Invitae Corporation
• 17. Koninklijke Philips N.V.
• 18. Microsoft Corporation
• 19. NVIDIA Corporation
• 20. PathAI, Inc.
• 21. Qiagen N.V.
• 22. Roche Diagnostics Corporation
• 23. Siemens Healthineers
• 24. Tempus AI, Inc.
• 25. Thermo Fisher Scientific